Sector valuations Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
NYSE
01:30:00 19/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 3.210 USD | -0.31% |
|
+0.94% | +16.73% |
| 14/08 | BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 | MT |
| 11/08 | Perspective Therapeutics's NET Program Data May Allow Phase 3 Trial Start, Value Inflection, RBC Says | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -3.14x | 1.55x | 0.12x | 599.23x | -1.61x | -1.64x | -.--% | 37Cr | |
| 33.26x | 4.43x | 1.28x | 5.94x | 17.67x | 24.86x | 0.96% | 4.88TCr | |
| -22x | 23.01x | -0.36x | 301.52x | -22.38x | -21.55x | -.--% | 4.54TCr | |
| 47.49x | 8.04x | 0.24x | 5.5x | 30.07x | 34.76x | -.--% | 4.12TCr | |
| 31.07x | 5.67x | -32.54x | 3.07x | 13.27x | 20.05x | -.--% | 3.97TCr | |
| 30.58x | 2.49x | 0.64x | 8.82x | 22.17x | 26.41x | 0.38% | 3.26TCr | |
| 33.96x | 24.36x | 2.25x | 5.56x | 25.28x | 26.44x | -.--% | 1.67TCr | |
| 23.34x | 2.61x | 0.68x | 2.04x | 8.84x | 13.69x | 1.15% | 1.41TCr | |
| 76.69x | 4.54x | -0.34x | 4.04x | 15.66x | 19.24x | -.--% | 1.37TCr | |
| 28.71x | 1.36x | 0.28x | 1.89x | 11.62x | 13.24x | -.--% | 1.31TCr | |
| 47.48x | 5.14x | 3.84x | 5.38x | 22.59x | 35.69x | 0.48% | 1.24TCr | |
| 60.83x | 5.2x | 0.38x | 9.27x | 26.36x | 28.79x | 0.44% | 1.13TCr | |
| -29.86x | 8.79x | 1.12x | 107.13x | -30.49x | -53.06x | -.--% | 1.06TCr | |
| -27.09x | 9.36x | -8.87x | 11359.22x | -22.44x | -22.1x | -.--% | 1.05TCr | |
| -28.87x | 9.27x | -2.75x | - | -25.49x | -25.55x | -.--% | 1.02TCr | |
| 34.25x | - | -0.11x | 17.95x | 33.32x | 32.36x | -.--% | 1.03TCr | |
| -31.52x | 9.11x | -7.2x | 82.81x | -21.05x | -20.49x | -.--% | 1.01TCr | |
| -16.41x | 678.75x | -0.33x | 10.47x | -16.92x | -16.34x | -.--% | 974.34Cr | |
| -36.2x | 18.94x | -30.93x | 6.17x | 150.8x | -2008.78x | -.--% | 931.77Cr | |
| Average | 13.29x | 45.70x | -3.82x | 696.44x | 12.49x | -99.68x | 0.18% | 1.89TCr | |
| Weighted average by Cap. | 19.58x | 27.77x | -4.42x | 391.33x | 12.16x | -40.68x | 0.24% |
- Stock Market
- Stocks
- CATX Stock
- Sector Perspective Therapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
